Immunetrics

Immunetrics takes a Quantitative Systems Pharmacology (QSP) approach to creating mechanistic mathematical models of biological systems, accelerating development of drugs, clinical diagnostics, and medical/commercial devices. We predict FDA-approved endpoints through in silico clinical trial simulations of acute or chronic inflammatory diseases. We deliver proprietary mathematical models encompassing biological pathways and interactions that span levels of detail from intracellular signaling pathways, cell-cell interactions, and organ systems. We also utilize complex analyses to help better understand your data and create novel hypotheses. Our robust bio-simulation platform represents 10+ years of work by our team of experts. Our capabilities allow our clients to bring their health care solutions to market more quickly, at a lower cost, and with decreased risk.

Immunetrics was founded in 2001 and collaborates regularly with the most significant names in drug development, medical devices, and academia.

Our team includes a cross disciplinary group of experts in physiology, molecular biology, immunology, computational biology, machine learning, and software engineering in a highly collaborative environment. We provide the expertise and experience to build functional models to inform our clients in their decision making process.

Immunetrics'​ offices and computing center are conveniently located in South Side of Pittsburgh, PA. Our city is the home of the University of Pittsburgh Medical Center, with its world-class Critical Care Medicine, Surgery and Immunology departments; Carnegie Mellon University, with its world-renowned Engineering and Mathematics groups; and the Pittsburgh Supercomputing Center.